相关实验视频

Updated: Jul 18, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

通过整合分子动力学模拟,药模拟和机器学习来发现浅层结合点的小分子结合物的计算工作流程:STAT3作为案例研究:STAT3

Nour Jamal Jaradat¹, Mamon Hatmal¹, Dana Alqudah²

¹Department of Medical Laboratory Sciences, Faculty of Applied Health Sciences, The Hashemite University, P.O. Box 330127, Zarqa, 13133, Jordan.

Journal of computer-aided molecular design

|August 19, 2023

概括

这项研究通过分析分子动力学来确定STAT3抑制的关键药. 这一发现有助于发现针对STAT3信号通路的新型抗癌药物.

科学领域:

生物化学生物化学
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

信号转换器和转录3激活器 (STAT3) 对于细胞过程至关重要,在癌症中经常失调.
STAT3抑制是一种有前途的抗癌策略,但由于蛋白质的SH2域和水分子相互作用,存在挑战.
发现强大的STAT3抑制剂是复杂的,需要先进的计算方法.

研究的目的:

从STAT3-连接体复合体的分子动力学模拟中提取药.
开发一种使用遗传功能算法和机器学习 (GFA-ML) 对STAT3抑制剂生物活性进行预测的模型.
通过选化学数据库来识别新的STAT3抑制剂.

主要方法:

分子动力学 (MD) 模拟在STAT3 SH2域-连接体复合体上进行.
从MD框架中提取了药.
采用GFA-ML模型与生物活性相关联,使用增强联体对应器数据集.
通过使用开发的药模型来选NCI数据库.

主要成果:

在188 ns的MD模拟后,确定了一种代表STAT3连接体结合的单一,显著的药.
GFA-ML模型有效地解释了抑制剂之间的生物活性变化.
数据库选发现了一种低微分子抑制剂,预计与STAT3 SH2域结合.

结论:

这项研究成功地确定了用于STAT3抑制的关键药,这对于理解带结合至关重要.
开发的GFA-ML方法为发现强大的STAT3抑制剂提供了可靠的方法.
这项研究为开发针对STAT3通路的新型抗癌疗法提供了有希望的途径.

关键词:

数据增强数据增强药物发现药物发现基因函数算法基因函数算法机器学习机器学习分子动态模拟分子动态模拟在QSAR中使用QSAR.在STAT3中,我们可以使用STAT3.

更多相关视频

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

相关概念视频

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Conserved Binding Sites

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...